Navitus Health Solutions, announced today the appointment of Sharon Faust, PharmD, MBA, CSP, as its new Chief Pharmacy Officer (CPO). She succeeds Brent Eberle, RPh, who is departing to become ...

The FDA’s priority review voucher program for rare pediatric diseases is set to lapse on Sept. 30 without congressional intervention.

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

Eberle, R.Ph., M.B.A., its new president. Eberle will join CivicaScript from Navitus Health Solutions, where he currently serves as Chief Pharmacy Officer. In this role, Eberle has been instrumental ...

Eminent business & pharmacy executive takes helm as company readies for new product launches in 2025 LEHI, Utah, Sep ...

The eligibility screening tool is only approved for the life of the current grant term. If a grantee is awarded funding under a subsequent grant, the grantee must resubmit their eligibility screening ...